Cargando…

Prostaglandin EP2 receptor antagonist ameliorates neuroinflammation in a two-hit mouse model of Alzheimer’s disease

BACKGROUND: Alzheimer’s disease (AD) causes substantial medical and societal burden with no therapies ameliorating cognitive deficits. Centralized pathologies involving amyloids, neurofibrillary tangles, and neuroinflammatory pathways are being investigated to identify disease-modifying targets for...

Descripción completa

Detalles Bibliográficos
Autores principales:	Banik, Avijit, Amaradhi, Radhika, Lee, Daniel, Sau, Michael, Wang, Wenyi, Dingledine, Raymond, Ganesh, Thota
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2021
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8605573/ https://www.ncbi.nlm.nih.gov/pubmed/34801055 http://dx.doi.org/10.1186/s12974-021-02297-7

Ejemplares similares

Lead Optimization Studies of Cinnamic Amide EP2 Antagonists
por: Ganesh, Thota, et al.
Publicado: (2014)

Inhibition of the prostaglandin EP2 receptor prevents long-term cognitive impairment in a model of systemic inflammation
por: Jiang, Chunxiang, et al.
Publicado: (2020)

Novel NADPH Oxidase-2 Inhibitors as Potential Anti-Inflammatory and Neuroprotective Agents
por: Juric, Matea, et al.
Publicado: (2023)

Microglial inhibition of neuroprotection by antagonists of the EP1 prostaglandin E2 receptor
por: Carlson, Noel G, et al.
Publicado: (2009)

Grapiprant: an EP4 prostaglandin receptor antagonist and novel therapy for pain and inflammation
por: Kirkby Shaw, Kristin, et al.
Publicado: (2015)

Timapiprant, a prostaglandin D2 receptor antagonist, ameliorates pathology in a rat Alzheimer’s model
por: Wallace, Charles H, et al.
Publicado: (2022)

Targeting EP2 Receptor for Drug Discovery: Strengths, Weaknesses, Opportunities, and Threats (SWOT) Analysis
por: Ganesh, Thota
Publicado: (2023)

Prostaglandin E2 EP4 Receptor Activation Attenuates Neuroinflammation and Early Brain Injury Induced by Subarachnoid Hemorrhage in Rats
por: Xu, Jie, et al.
Publicado: (2017)

Prostaglandin E receptor 4 (EP4) promotes colonic tumorigenesis
por: Chang, Jian, et al.
Publicado: (2015)

A novel prostaglandin E receptor 4 (EP4) small molecule antagonist induces articular cartilage regeneration
por: Jin, Yunyun, et al.
Publicado: (2022)

A Novel Small Molecular Prostaglandin Receptor EP4 Antagonist, L001, Suppresses Pancreatic Cancer Metastasis
por: He, Jiacheng, et al.
Publicado: (2022)

Cloning and expression of the rabbit prostaglandin EP2 receptor
por: Guan, Youfei, et al.
Publicado: (2002)

LY3127760, a Selective Prostaglandin E4 (EP4) Receptor Antagonist, and Celecoxib: A Comparison of Pharmacological Profiles
por: Jin, Yan, et al.
Publicado: (2017)

IGF-1R Inhibitor Ameliorates Neuroinflammation in an Alzheimer’s Disease Transgenic Mouse Model
por: Sohrabi, Mona, et al.
Publicado: (2020)

Ketogenic diet ameliorates cognitive impairment and neuroinflammation in a mouse model of Alzheimer’s disease
por: Xu, Yunlong, et al.
Publicado: (2021)

Regulation of prostaglandin EP(1) and EP(4) receptor signaling by carrier-mediated ligand reuptake
por: Chi, Yuling, et al.
Publicado: (2014)

Opposing effects of prostaglandin E(2) receptors EP3 and EP4 on mouse and human β-cell survival and proliferation
por: Carboneau, Bethany A., et al.
Publicado: (2017)

Inhibitory effects of prostaglandin EP(4 )receptors on human eosinophils
por: Luschnig-Schratl, Petra, et al.
Publicado: (2009)

Role of EP(2) and EP(4) receptors in airway microvascular leak induced by prostaglandin E(2)
por: Jones, Victoria C, et al.
Publicado: (2016)

Milrinone Ameliorates the Neuroinflammation and Memory Function of Alzheimer’s Disease in an APP/PS1 Mouse Model
por: Chen, Qingyou, et al.
Publicado: (2021)

The pharmacological effect of BGC20-1531, a novel prostanoid EP(4) receptor antagonist, in the Prostaglandin E(2) human model of headache
por: Antonova, Maria, et al.
Publicado: (2011)

A Prospective, Randomized, Masked, Placebo‐Controlled Multisite Clinical Study of Grapiprant, an EP4 Prostaglandin Receptor Antagonist (PRA), in Dogs with Osteoarthritis
por: Rausch‐Derra, L., et al.
Publicado: (2016)

Dual Blockade of EP2 and EP4 Signaling is Required for Optimal Immune Activation and Antitumor Activity Against Prostaglandin-Expressing Tumors
por: Francica, Brian J., et al.
Publicado: (2023)

In silico screening of neurokinin receptor antagonists as a therapeutic strategy for neuroinflammation in Alzheimer’s disease
por: Satarker, Sairaj, et al.
Publicado: (2021)

The role of the EP receptors for prostaglandin E(2) in skin and skin cancer
por: Rundhaug, J. E., et al.
Publicado: (2011)

Gene expression of prostaglandin EP4 receptor in three canine carcinomas
por: Musser, Margaret L., et al.
Publicado: (2020)

Prostaglandin E2/EP Signaling in the Tumor Microenvironment of Colorectal Cancer
por: Mizuno, Rei, et al.
Publicado: (2019)

Prostaglandin E2 receptor EP1 expression in vulvar cancer
por: Buchholz, Anna, et al.
Publicado: (2022)

Neuroinflammation in mouse models of Alzheimer's disease
por: Saito, Takashi, et al.
Publicado: (2018)

Prostaglandin E2 promotes human CD34(+) cells homing through EP2 and EP4 in vitro
por: Wang, Yaqun, et al.
Publicado: (2017)

Concerted EP2 and EP4 Receptor Signaling Stimulates Autocrine Prostaglandin E(2) Activation in Human Podocytes
por: Mangelsen, Eva, et al.
Publicado: (2020)

The prostaglandin receptor EP2 determines prognosis in EP3-negative and galectin-3-high cervical cancer cases
por: Dietlmeier, Sebastian, et al.
Publicado: (2020)

Prostacyclin-IP signaling and prostaglandin E(2)-EP2/EP4 signaling both mediate joint inflammation in mouse collagen-induced arthritis
por: Honda, Tetsuya, et al.
Publicado: (2006)

Prostaglandin receptors EP and FP are regulated by estradiol and progesterone in the uterus of ovariectomized rats
por: Blesson, Chellakkan S, et al.
Publicado: (2012)

Role of the Prostaglandin E(2) EP1 Receptor in Traumatic Brain Injury
por: Glushakov, Alexander V., et al.
Publicado: (2014)

Heterodimerization of the prostaglandin E2 receptor EP2 and the calcitonin receptor CTR
por: Matsubara, Shin, et al.
Publicado: (2017)

Beneficial Outcome of Urethane Treatment Following Status Epilepticus in a Rat Organophosphorus Toxicity Model
por: Rojas, Asheebo, et al.
Publicado: (2018)

Characterization of the Signaling Modalities of Prostaglandin E2 Receptors EP2 and EP4 Reveals Crosstalk and a Role for Microtubules
por: Vleeshouwers, Ward, et al.
Publicado: (2021)

The two-hit hypothesis for neuroinflammation: role of exogenous ATP in modulating inflammation in the brain
por: Fiebich, Bernd L., et al.
Publicado: (2014)

A prostaglandin E (PGE) receptor EP4 antagonist protects natural killer cells from PGE(2)-mediated immunosuppression and inhibits breast cancer metastasis
por: Ma, Xinrong, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_6m0v789dueo1hlc77he806likl